Last updated: February 8, 2024
Sponsor: Oregon Health and Science University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vision Loss
Eye Disease
Treatment
Laser Custom Corneal Collagen Cross-Linking
Clinical Study ID
NCT03760432
6612-CXL
R01EY028755
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of keratoconus
- Minimum corneal thickness of 410 microns
Exclusion
Exclusion Criteria:
- Inability to maintain fixation for OCT imaging
- Inability to commit to required study visits
- Inability to give informed consent
- Eyes with concurrent retinal diseases, glaucoma, or other eye conditions that maylimit the visual outcome after surgery
- Mature cataracts if found to limit visual potential to worse than 20/40
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Laser Custom Corneal Collagen Cross-Linking
Phase:
Study Start date:
June 20, 2018
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Oregon Health & Science University
Portland, Oregon 97239
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.